Research Article

Safety Evaluation of the Polyherbal Formulation NawaTab: Acute and Subacute Oral Toxicity Studies in Rats

Table 3

Hematological parameters of NawaTab-treated rats in the subacute toxicity study.

ParametersControlNawaTab (mg/kg BW)
2505001000

Males
WBC (×103 cells/μL)4.02 ± 0.335.48 ± 0.525.04 ± 0.665.05 ± 0.56
NE (%)5.64 ± 3.793.62 ± 1.573.37 ± 1.231.45 ± 0.09
LY (%)82.44 ± 4.2086.26 ± 1.8385.03 ± 3.7185.98 ± 1.20
MO (%)10.42 ± 1.268.82 ± 0.6410.77 ± 2.6811.25 ± 1.23
EO (%)1.08 ± 0.201.02 ± 0.150.57 ± 0.091.00 ± 0.30
BA (%)0.42 ± 0.120.28 ± 0.020.27 ± 0.030.32 ± 0.05
RBC (×106 cells/μL)7.89 ± 0.287.67 ± 0.117.92 ± 0.127.97 ± 0.18
HGB (g/dL)14.76 ± 0.2314.90 ± 0.3214.83 ± 0.5014.90 ± 0.31
HCT (%)47.16 ± 1.4247.04 ± 0.6748.10 ± 1.7947.82 ± 0.80
PLT (×103 cells/μL)785.0 ± 69.4789.0 ± 29.6715.0 ± 47.5680.0 ± 52.1
MCV (fL)59.80 ± 0.8961.30 ± 0.5960.70 ± 1.9560.10 ± 0.95
MCH (pg)18.80 ± 0.4819.40 ± 0.2118.70 ± 0.5918.70 ± 0.33
MCHC (g/dL)31.34 ± 0.5831.68 ± 0.2830.87 ± 0.2631.15 ± 0.30
RDW (%)12.30 ± 1.0812.02 ± 0.6912.20 ± 0.1511.15 ± 0.12

Females
WBC (×103 cells/μL)2.28 ± 0.532.61 ± 0.343.36 ± 0.513.51 ± 0.31
NE (%)10.74 ± 3.519.20 ± 4.804.88 ± 2.142.70 ± 0.23
LY (%)76.18 ± 4.5576.70 ± 3.8082.22 ± 2.4885.85 ± 1.27
MO (%)10.06 ± 1.1312.50 ± 1.9811.56 ± 0.3610.35 ± 1.21
EO (%)1.04 ± 0.251.15 ± 0.180.58 ± 0.080.52 ± 0.13
BA (%)1.98 ± 0.940.45 ± 0.120.76 ± 0.240.58 ± 0.05
RBC (×106 cells/μL)8.07 ± 0.127.52 ± 0.107.97 ± 0.177.99 ± 0.11
HGB (g/dL)15.66 ± 0.2714.52 ± 0.4915.40 ± 0.3215.72 ± 0.37
HCT (%)46.86 ± 0.8944.72 ± 1.0846.84 ± 1.3048.58 ± 0.74
PLT (×103 cells/μL)596.0 ± 74.8619.5 ± 78.2720.6 ± 72.8759.8 ± 31.1
MCV (fL)58.10 ± 0.9259.50 ± 0.7358.70 ± 0.5360.90 ± 1.20
MCH (pg)19.40 ± 0.3619.30 ± 0.4919.30 ± 0.2419.70 ± 0.44
MCHC (g/dL)33.46 ± 0.5832.48 ± 0.8232.92 ± 0.4732.38 ± 0.42
RDW (%)11.16 ± 0.3910.9 ± 0.6411.28 ± 0.7110.93 ± 0.28

Data are expressed as mean ± S.E.M, n = 5 animals/sex/group.